Lv53
1390 积分 2022-09-19 加入
Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled Trial
6天前
已完结
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4 ‐ IgG ‐Positive NMOSD
9天前
已关闭
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis
12天前
已完结
Pathogenesis exploration of lgG4-related disease: From the traditional central dogma and its remodeling perspective
22天前
已关闭
The Far Side of Heterogeneity
22天前
已完结
B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives
22天前
已完结
Fibrotic phenotype of IgG4-related disease
22天前
已完结
Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Current Evidence and Emerging Diagnostic Technologies
28天前
已完结
Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index
1个月前
已关闭
Real-world safety of satralizumab in neuromyelitis optica spectrum disorder: a FAERS-based risk stratification study
1个月前
已完结
皖公网安备34019202002308
